Diethylstilboestrol: I, Pharmacology, Toxicology and carcinogenicity in humans

Loading...
Thumbnail Image

Date

Authors

Marselos, M.
Tomatis, L.

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Type of the conference item

Journal type

peer-reviewed

Educational material type

Conference Name

Journal name

Eur J Cancer

Book name

Book series

Book edition

Alternative title / Subtitle

Description

Diethylstilboestrol is still used as an adjunct palliative treatment in certain patients with breast and prostate cancer. Its pharmacological, toxicological and carcinogenic properties are reviewed. In addition to the usual untoward effects following subacute or chronic administration of oestrogens, treatment with diethylstilboestrol has been associated with serious cardiovascular sequelae. Most characteristic are, however, the carcinogenic properties of this drug. Many epidemiological data provide evidence that prenatal exposure to diethylstilboestrol is causally associated with vaginal and cervical clear-cell adenocarcinomas, a very rare type of cancer in the unexposed female population. The intrauterine exposure of males leads to an increased risk of testicular cancer, although the data are less conclusive in this respect. There is some evidence that administration of diethylstilboestrol in large doses to adult women during pregnancy increases the risk of subsequent breast cancer and it probably increases the incidence of endometrial carcinoma, as has been shown with other similar oestrogens given chronically for menopausal symptoms.

Description

Keywords

Abnormalities, Drug-Induced, Adolescent, Adult, Cardiovascular Diseases/chemically induced, Child, Diethylstilbestrol/*adverse effects/*pharmacology/therapeutic use, Environmental Exposure, Female, Genitalia/abnormalities, Humans, Male, Neoplasms/*chemically induced, Pregnancy, Prenatal Exposure Delayed Effects

Subject classification

Citation

Link

http://www.ncbi.nlm.nih.gov/pubmed/1627392

Language

en

Publishing department/division

Advisor name

Examining committee

General Description / Additional Comments

Institution and School/Department of submitter

Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής

Table of contents

Sponsor

Bibliographic citation

Name(s) of contributor(s)

Number of Pages

Course details

Endorsement

Review

Supplemented By

Referenced By